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Abstract 
AIM
To test the fujinon intelligent color enhancement (FICE) 
in identifying dysplastic or adenomatous polyps in familial 
adenomatous polyposis (FAP) patients.
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METHODS 
Seventy-six consecutive FAP patients, already treated 
by colectomy and members of sixty-five families, were 
enrolled. A FICE system for the upper gastro-intestinal 
tract with an electronic endoscope system and a standard 
duodenoscope (for side-viewing examination) were used 
by two expert examiners. Endoscopic resection was 
performed with diathermic loop for polyps ≥ 6 mm and 
with forceps for polyps < 6 mm. Formalin-fixed biopsy 
specimens were analyzed by two expert gastrointestinal 
pathologists blinded to size, location and number of FAP-
associated fundic gland polyps.
RESULTS
Sixty-nine (90.8%) patients had gastric polyps (34 only 
in the corpus-fundus, 7 only in the antrum and 28 in the 
whole stomach) and 52 (68.4%) in duodenum (7 in the 
bulb, 35 in second/third duodenal portion, 10 both in 
the bulb and the second portion of duodenum). In the 
stomach fundus after FICE evaluation, 10 more polyps 
were removed from 10 patients for suspicious features of 
dysplasia or adenomas, but they were classified as cystic 
fundic gland after histology. In the antrum FICE identified 
more polyps than traditional endoscopy, showing a better 
tendency to identify adenomas and displastic areas. In 
the duodenum FICE added a significant advantage in 
identifying adenomas in the bulb and identified more 
polyps in the Ⅱ/Ⅲ portion.
CONCLUSION
FICE significantly increases adenoma detection rate in FAP 
patients but does not change any Spigelman stage and 
thus does not modify patient’s prognosis and treatment 
strategies.
Key words: Fujinon intelligent color enhancement; Familial 
adenomatous polyposis; Spigelman; Endoscopy; Polyp; 
Adenoma; Stomach; Duodenum
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Colon endoscopic surveillance and prophylactic 
colectomy have strongly reduced mortality due to 
colorectal carcinoma and have improved survival of fa-
milial adenomatous polyposis (FAP) patients, leading to 
the development of surveillance for extra-colonic cancers. 
Polyps in the duodenum and stomach are frequent 
findings in FAP. The timing of endoscopic and histology 
surveillance is currently a great challenge. Spectral 
estimation by fujinon intelligent color enhancement 
(FICE) may identify dysplasia and discriminate between 
adenomatous and non-adenomatous polyps. Interestingly, 
application of FICE to FAP patients significantly increases 
the detection of adenomas but does not yet change the 
prognosis, surveillance program and treatment strategies.
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INTRODUCTION
Familial adenomatous polyposis (FAP) is an autosomal 
dominant inherited syndrome characterized by the 
development of colorectal cancer by the age of 40 
years in nearly 100% of individuals[1]. Colon Endoscopic 
surveillance and prophylactic colectomy have strongly 
reduced mortality due to colorectal carcinoma and 
have improved survival of FAP patients with minimal 
consequences[2,3], leading to the introduction of sur­
veillance strategies for the prevention of other extra­
colonic malignancies[4].
The duodenum is the second most common site 
of polyps development after colon, with a life­time risk 
of duodenal adenomas that approaches 100% in FAP 
affected individuals[5,6]. The cumulative risk of duodenal 
cancer or high grade of dysplasia by the age of 60 years 
is 4%­10%[6­8].
Endoscopic surveillance and removal of neoplastic 
tissue is useful in the prevention of duodenal cancer[8]. 
However, the choice of treatment and the optimal timing 
of surveillance based on endoscopic and histopathology 
examination for each patient is currently a great challenge. 
Currently the surveillance of duodenum is based on the 
Spigelman classification of duodenal adenomatosis (Table 
1); however, this staging system has low predictive values 
and has never been validated[6,8].
Gastric polyps are also a common finding in patients 
with FAP: they mostly consist of FAP­associated fundic 
gland polyps (FGPs) reported to occur at variable 
rates, up to 88%[9,10], against a strongly smaller rate 
(0.8%­5.0%)[11,12] in non­FAP subjects who undergo an 
esophagogastroduodenoscopy (EGD).
FGPs have historically been considered non­neoplastic 
lesions without malignant potential[13]; however recent 
studies have questioned this assumption reporting high 
rates of low and high grade dysplasia (up to 54%)[9,14,15]. 
In particular, European and Asian registries of FAP 
patients proved the presence of gastric carcinoma arising 
from FGPs in FAP patients and an incidence of gastric 
adenocarcinoma between 0.6% and 4.0%[16­19].
Other common types of gastric polyps are repre­
sented by adenomas (gastric foveolar or intestinal type­
gastric adenomas and pyloric gland adenomas) which are 
reported in approximately 10% of gastric polyps in FAP 
patients[10,20,21] and which can arise in the gastric antrum, 
in the gastric body­fundus or in the context of FGP[22]. So, 
identification of dysplastic lesions or adenomatous tissue 
in these patients is often made difficult by the great 
number of polyps (up to hundreds) and by the patchy 
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distribution of dysplasia.
By now, dysplasia finding in this subgroup of subjects 
is made on the basis of random biopsies[9] which lead 
to a time consuming, laborious and poorly performing 
procedure, that can result in a high rate of missed le­
sions. According to that, it would be useful identifying 
FGPs at risk of malignant degeneration.
A better characterization of patients, an optimized 
program of surveillance and a good survival are possible 
with a selective and complete asportation and with a 
careful histological evaluation.
It is well known that is possible to predict the histology 
of a mucosal lesion by observing the crypt orifices (the so 
called pit pattern) of mucosal glands[23] and the capillary 
pattern of the mucosa[24]. Several endoscopic imaging 
techniques have been proposed to enhance the details of 
these patterns[25]. Among these, chromoendoscopy is a 
widely applied staining method that uses biocompatible 
dye agents which accumulate within crypt orifices during 
endoscopy[26]. Although chromoendoscopy is effective 
for many applications, it still has some problems, such 
as difficulty in achieving complete and even coating of 
the mucosal surface with the dye, the extra cost of the 
equipment needed for dye spraying and the extra time 
required to perform the procedure. Moreover, traditional 
chromoendoscopy isn’t able to enhance the capillary 
pattern, whose evaluation is essential in early diagnoses of 
malignant lesions[24]. In attempt to resolve these problems, 
other endoscopic technologies have been developed. 
Fujinon intelligent color enhancement (FICE™, Fujinon 
Corp, Saitama, Japan) represents a spectral estimation 
technique based on arithmetically processing of a white­
light image captured by a video endoscope and sent 
to the spectral­estimation matrix­processing circuit. 
The image of the white­light endoscopic observation is 
resolved in each color image of the red, green and blue 
signal. Next, each resolved image is converted into various 
presumed wavelength images by a pixel unit. The images 
of an arbitrary single wavelength are then extracted and 
reconstructed. Due to its variable setting functions (up 
to 10) it is possible to select flexibly the most suitable 
wavelengths required for examination. Preliminary studies 
suggested that FICE successfully achieved enhancements 
of real­time observations of mucosal and microvascular 
patterns[27,28].
The light penetration into the mucosa varies acc­
ording to the wavelengths: Those in the 400­500 nm 
range are ideal for analyzing surface structures whereas, 
because of the absorption properties of hemoglobin, 
longer wavelengths of about 550 nm are more effective 
for the visualization of blood vessels.
FICE seems able to discriminate between adenomatous 
and non­adenomatous polyps and to identify the presence 
of dysplasia[29­32]. Few studies have been conducted 
to determine the efficacy of chromoendoscopy, both 
traditional and virtual, in the evaluation of duodenal and 
peri­ampullary adenomatous polyps in FAP patients[33­35]. 
Interestingly, FICE application in the discrimination 
between neoplastic and non­neoplastic gastric lesions 
has not been throughly investigated[36­39], and no data 
are available about FICE in evaluating FGPs dysplasia or 
application of FICE for the screening of FAP patients.
In FAP cohort, the specific identification of who is 
at a greater risk of cancer development could be of 
paramount importance to assure a personalized program 
of surveillance or a therapeutic intervention.
The primary aim of this study was to assess the 
capability of FICE in identifying gastric polyps with dysplastic 
or adenomatous tissue in comparison to traditional 
endoscopy and in identifying a greater number of duodenal 
adenomas with advanced histological features.
Secondary aim was to assess the capability of FICE in 
identifying adenomas not seen on white light evaluation.
MATERIALS AND METHODS
Patients
Seventy­six consecutive FAP patients, already treated 
by colectomy and members of sixty-five families, were 
enrolled. Exclusion criteria were: Uncorrectable coa­
gulopathy, inability to give informed consent, age < 
18 years, prior gastro­duodenal surgery or a personal 
history of gastro­duodenal cancer. All patients underwent 
a surveillance esophagogastroduodenoscopy (EGD) 
in deep sedation at the Gastroenterology U.O. of the 
Azienda Ospedaliero Universitaria di Careggi, Firenze, 
Italy. Written informed consent were obtained before 
EGD and sedation.
Endoscopy
A FICE system (EG­590ZW; Fujinon Corp, Saitama, 
Table 1  Demographic features
Features Patients
Total 76
Age (yr) Mean 40.3 (24-64)
Gender
  Male 41 (53.9%)
  Female 35 (46.1%)
Prior surgery
  IRA 10 (13.2%)
  IPAA 66 (86.8%)
Chemoprevention 16 (21.1%)
NSAIDS intake 17 (22.4%)
Tobacco exposure 21 (27.6%)
PPI/anti-H2 intake 14 (18.4%)
Family history of GI malignancies
  None 31 (40.8%)
  1 member 32 (42.1%)
  2 members 10 (13.2%)
  3 members 3 (3.9%)
Spigelman duodenal stage
  0 28 (36.8%)
  Ⅰ 7 (9.2%)
  Ⅱ 34 (44.8%)
  Ⅲ 7 (9.2%)
  Ⅳ 0 (0.0%)
IRA: Total colectomy and ileo-rectal anastomosis; IPAA: Total proctocolectomy 
and ileopouch-anal anastomosis; NSAIDS: Non steroidal anti-inflammatory 
drugs; PPI: Proton pump inhibitors.
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Japan) for the upper gastro­intestinal tract with an 
electronic endoscope system (EPX­4400; Fujinon Corp, 
Saitama, Japan) was used for this study. In this system, 
ten channels with different predefined combinations of 
absorption wavelengths are available. We used channel 
5, corresponding to R 500 nm, G 480 nm, B 420 nm, on 
the basis of previous studies.
A standard duodenoscope was used for side­viewing 
examination. Because this model of duodenoscope does 
not support FICE system, ampullary and periampullary 
evaluations were not included in the analysis. All of the 
endoscopic procedures were performed by two experts 
examiners.
“A” operator performed the exam on white light, while 
“B” operator used only FICE system for gastroduodenal 
visualization. Each EGD was divided into three phases.
During the first phase, “A” operator observed stomach 
and duodenum by white light recording photographic 
images of suspected polyps and pointing them. We 
intended suspected polyps on white light those larger 
than 1 cm and those with irregular shape or surface 
features.
During the second phase, “B” operator performed 
the exam using FICE and, like “A” operator, recorded 
photographic images of suspected polyps on the basis of 
Kudo classification[23] and capillary pattern, and pointed 
them.
Kudo classification classifies mucosal crypt patterns into 
five types, with type Ⅰ and Ⅱ predicting non­adenomatous 
lesions and type Ⅲ­Ⅴ predicting adenomatous lesions.
Hyperplastic polyps were suspected when the surface 
showed pale color with only minute thin superficial 
(couperose­like) vessels and round or asteroid pattern 
(type Ⅰ and Ⅱ). Adenomas were suspected in the pre­
sence of increased vascular density (darkening of the 
mucosal pattern or a fine meshwork of brownish/bluish 
vessels) and a typical tubular or gyrus­like pattern (type 
Ⅲ­Ⅳ). Finally, type V have a non structural pattern which 
identifies high dysplastic or yet carcinomatous lesions. 
During this phase we intended suspected those 
lesions with a pit pattern type Ⅲ­Ⅴ and those with an 
increased capillary density.
During the third phase, after the two endoscopists’ 
cross­evaluation, lesions which seemed suspected only 
by FICE, only by white light or by both methods were 
resected or biopsied according to Kudo class.
Endoscopic resection was performed with diatermic 
loop for polyps ≥ 6 mm and with forceps for polyps < 
6 mm. The size was estimated using on open biopsy 
forceps (8 mm) for comparison and recorded as smaller 
than 6 mm, 6 to 10 mm, 11 to 20 mm and greater than 
20 mm.
The total number of FGPs was documented as below: 
0 to 2 polyps, 3 to 20, 21 to 30 and more than 30 polyps. 
On the basis of location we identified: Fundus­corpus, 
antrum, duodenal bulb, Ⅱ°/Ⅲ° duodenal portion.
For fundic polyps seen on white light, the number 
of FGPs from which a biopsy specimen was taken was 
based on the total number of FGPs present: 3 biopsies if 
3­20 polyps, 5 biopsies if 21­30 polyps, 7 biopsies if > 30 
polyps[9]. 
On FICE, only suspected polyps (Kudo Ⅲ­Ⅴ, high 
capillary density) were removed.
For antral and bulbar polyps, all of them were re­
moved or biopsied both on withe light than on FICE.
In the second and third duodenal portion, on white 
light only suspected polyps were resected or biopsied, 
while on FICE were biopsied those with Kudo Ⅴ and 
those with Kudo Ⅳ and high capillary density.
Macroscopic classification of lesions followed the Paris 
classification[40] as polyp, superficially flat or depressed 
lesion, and lateral spreading tumor.
Histology
All biopsy specimens, fixed in 10% neutral buffered 
formalin, were analyzed by two expert gastrointestinal 
pathologists blinded to size, location and number of 
FGPs.
In the case of multiple lesions in the same patient, 
each lesion was identified and placed in different flasks. 
Lesions were histological classified in adenomatous, 
hyperplastic or inflammatory polyps, fundic gland polyps, 
and metaplastic areas.
Adenomatous polyps were classified according to 
OMS classification: Tubular if holding more than 75% of 
tubular glands, villus if holding more than 75% of villus 
glands, tubulo­villus if not prevailing none of the two 
patterns.
Dysplasia was classified according to Vienna criteria[41] 
in low grade if holding nuclear enlargement, stratification 
and hyperchromasia with overall preservation of nuclear 
polarity; high grade as above but with nuclear polarity 
loss and glandular crowding; indefinite for dysplasia 
if present mild nuclear enlargment and insufficient 
hypercromasia to be classified as dysplasia or if present a 
significant obscuring background inflammation. 
The stage of duodenal polyposis was graded according 
to Spigelman classification modified sec. Saurin[42], which 
take into account duodenal polyp number, size, histological 
type and grade of dysplasia. It was noted before and after 
FICE evaluation.
Statistical analysis
The diagnostic performances (sensitivities, specificities, 
positive and negative predictive values) of FICE and 
WL were determined by comparing the endoscopic 
diagnoses with the histo-pathological findings. To identify 
associations of demographic, clinical and endoscopic 
features with the presence of FGP dysplasia or with 
adenomas, the Fisher exact test was used to study 
univariable associations of categoric demographic and 
endoscopic factors with the presence of dysplasia or 
adenomatous tissue. The Student t test was used 
for continuous factors. A P value “two tailed” < 0.05 
was considered statistical significant. The strength of 
association was calculated by odds ratio (OR). The 
statistical methods of this study were reviewed by S. 
Milani, University of Florence.
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RESULTS
Seventy­six consecutive FAP patients (41 male and 
35 female; mean age 40.3 years old, range 24­64) 
underwent EGD. Among all patients, 69 (90.8%) had 
gastric polyps (34 only in the corpus­fundus, 7 only in 
the antrum and 28 in the whole stomach) and 52 (68.4%) 
in duodenum (7 in the bulb, 35 in second/third duodenal 
portion, 10 both in the bulb and the second portion of 
duodenum) (Table 2).
Identification of polyps in the stomach
Fundus: 62 patients had a widespread fundic polyposis 
(81.6%); 52 of them had more than 30 fundic polyps 
(68.5%), 3 between 21 and 30 (3.9%) and 7 between 5 
and 20 (9.2%).
On white light visualization, 397 polyps in 62 patients 
(6.4 polyps per patient) were removed. Three were 
hyperplastic polyps, 7 inflammatory while the rest were 
cystic fundic gland polyps. No polyp harboured dysplasia 
nor adenomatous foci (specificity 100%, sensitivity NV, 
positive predictive value NV, negative predictive value 
100%, 95%CI) (Table 3).
After FICE evaluation, 10 polyps were removed 
from 10 patients on the basis of suspicious features of 
dysplasia or adenomatous tissue. All of them were cystic 
fundic gland polyps, none of them harboring dysplasia 
or adenomatous foci (specificity 97%; sensitivity NV; 
positive predictive value 0%; negative predictive value 
100%) (Table 4).
Thirty­eight patients with fundic polyposis had also 
duodenal polyposis (61.2%), while among the 14 
patients without fundic polyps, 10 had polyps in the 
duodenum (71.4%). Thus the presence of fundic polyps 
doesn’t correlate with a higher risk to develop duodenal 
polyps (P = 0.55; OR = 0.6).
Antrum: A total of 56 polyps were identified and 
removed in the antrum of 35 patients (average 1.6 
polyps per patient). Twenty­four polyps were identified 
in 35 patients by white light endoscopy (0.7 polyps 
per patient); 21 of them were tubular adenomas with 
low grade dysplasia while 3 were inflammatory polyps 
(specificity 88.0%; sensitivity 67.7%; positive predictive 
value 87.5%; negative predictive value 68.7%) (Table 5).
Beside polyps seen with conventional endoscopy, 
FICE was further able to identify 32 polyps in 28 patients. 
They were 7 tubular adenomas with low grade dysplasia, 
14 inflammatory polyps, 3 areas with low grade dysplasia 
in the context of flogistic mucosa, 8 metaplasic areas 
(specificity 12.0%; sensitivity 100%; positive predictive 
value 58.5%; negative predictive value 100%) (Table 6).
FICE identified a higher number of polyps than 
traditional endoscopy (56 vs 24; P < 0.0001), showing a 
better, but not statistically significant, tendency to identify 
adenomas and displastic areas (31 vs 21; P = 0.0857). 
All but 4 polyps missed out by white light, were flat.
Eighteen of patients with antral lesions (51.4%) had 
polyps also in the duodenum. There is no relationship 
between presence of dysplasia in antral stomach and 
Spigelman advanced stages (P = 1; OR = NV).
Identification of duodenal polyps
Bulb: 21 polyps were seen in 17 patients (1.2 polyps 
per patient). All of them were endoscopically removed. 
White light endoscopy identified 14 polyps in 12 patients; 
8 polyps were inflammatory, while 6 were tubular 
adenomas with low grade dysplasia (specificity 0%; 
sensitivity 46.2%; positive predictive value 42.9%; 
negative predictive value 0%) (Table 7).
During FICE evaluation, beside polyps seen with 
conventional endoscopy, 7 more polyps in 7 patients, five 
Table 2  Stomach and duodenum polyps
  Patients   Patients
Fundus 34 (49.3%) Bulb   7 (13.5%)
Antrum   7 (10.1%) Ii°/iii° portion 35 (67.3%)
Fundus + antrum 28 (40.6%) Bulb+ii°/iii° 10 (19.2%)
Total stomach 69 (100%) Total duodenum 52 (100%)
Table 3  Features of fundic polyps identified by white light 
endoscopy
P1-P3 P4-P10 P11-P24 P25-P55 P56-P397
Kudo Ⅰ Ⅱ Ⅱ Ⅱ Ⅰ
Size (mm) 5 5 6-10 5 5
Paris CL Is Is Is Is Is
Histology HYP IN FGP FGP FGP
IN: Inflammatory; FGP: Fundic gland polyp; IP: Hyperplastic.




Size (mm) 5 5
Paris CL Is Is
Histology FGP FGP
FGP: Fundic gland polyp.
Table 5  Features of antral polyps identified by white light 
endoscopy
P1-P3 P4 P5-P10 P11-P17 P18-P24
Kudo Ⅱ ⅢS ⅢS ⅢS Ⅳ
Size (mm) 6-10 6-10 5 5 5
Paris CL Ⅱa Ⅱa + Ⅱc Ⅰs Ⅰs Ⅰs
Histology IN TA, LGD TA, LGD TA, LGD TA, LGD
Spigelman 0 0 I° 0 0
IN: Inflammatory; TA: Tubular adenoma; LGD: Low grade dysplasia.
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Table 7  Features of bulbal polyps identified by white light endoscopy
of them new, were discovered. All of them were tubular 
adenomas with low grade dysplasia (specificity 62.5%; 
sensitivity 100%; positive predictive value 81.3%; 
negative predictive value 100%) (Table 8). 
FICE was able to see further 7 polyps than traditional 
endoscopy, and it was able to identify a quite significant 
higher number of polyp in the duodenal bulb (21 vs 14; 
P = 0.069). FICE added a statistical significant advantage 
in identifying adenomas (13 vs 6; P = 0.03). All FICE 
identified polyps were flat lesions. All patients with bulbal 
polyps had also lesions in the gastric fundus and no 
adenoma in the antrum.
All patients with bulbal adenomas had polyps in the 
second/third portion of duodenum, while patients with 
inflammatory polyps had a Spigelman’s stage 0.
Ⅱ°/Ⅲ° duodenal portion: Totally, 391 polyps in 45 
patients (8.7 polyps per patient) were identified. Of them, 
105 were removed or biopsied (26.5%). Conventional 
endoscopy identify 324 polyps in 45 patients (7.2 polyps 
per patient). Of them, 94 were removed or biopsied 
(2.1 polyps per patient) and they resulted: 80 tubular 
adenomas with low grade dysplasia, 10 inflammatory 
polyps and 4 tubulo­villous adenomas with low grade 
dysplasia. No case of high grade dysplasia (3 suspected). 
(Table 9). FICE identified further 67 polyps in 35 patients 
and 11 were removed or biopsied in 11 subjects. All of 
them were tubular adenomas with low grade dysplasia. 
No case of high grade dysplasia (Table 10). FICE was 
able to identify a higher number of polyps than traditional 
endoscopy (8.7 vs 7.2; P < 0.001). All polyps not seen 
on white light were flat lesions.
Thirty­five of patients with duodenal polyposis 
had also polyps in the fundus, 4 had adenomas and 2 
dysplastic areas in the antrum, thus FICE didn’t change 
any Spigelman stage just defined with conventional 
endoscopy. 
DISCUSSION
Duodenal adenomatous polyps are common mani­
festations of FAP found in 30% to 90% of patients, with 
a life time risk approaching 100%[5,6,43]. While rare in 
the general population (0.01%­0.04% of incidence at 
an average age of 65 years)[43], the risk of duodenal or 
periampullary cancer is increased several hundreds fold 
in FAP patients (estimated cumulative risk of 4.5% by 
age 57 and a median age at presentation of 52 years)[6,8]. 
Duodenal cancer is the second most common cause of 
disease­related mortality in patients with FAP, only the 
Table 6  Features of antral polyps identified by fujinon intelligent color enhancement
P25 P26 P27 P28-P30 P31 P32-P33 P34-P35 P36-P38 P39-P44 P45-P49 P50-P53 P54-P56
Kudo Ⅴ Ⅴ ⅢS ⅢL ⅢL Ⅳ Ⅳ ⅢL ⅢL ⅢS ⅢS Ⅴ
Size (mm) 5 5 5 6-10 5 5 6-10 5 5 5 6-10 5
Paris CL Ⅱb Ⅱa Ⅱb Ⅱb Ⅱa Ⅱb Ⅱa Ⅱa Ⅱb Ⅱb Ⅰs Ⅱb
Histology IN LGD IN LGD IN LGD MET MET MET MET IN IN IN TA LGD TA LGD
Spigelman Ⅲ° Ⅱ° Ⅰ° Ⅱ° Ⅱ° 0 Ⅱ° 0 0 0 Ⅰ° Ⅱ°
IN: Inflammatory; TA: Tubular adenoma; LGD: Low grade dysplasia; MET: Metaplasia.
P1-P5 P6-P8 P9 P10-P12 P13 P14
Kudo Ⅱ ⅢS ⅢS ⅢL Ⅳ Ⅳ
Size (mm) 5 6-10 6-10 5 6-10 6-10
Paris CL Ⅰs Ⅰs Ⅰs Ⅱa Ⅰs Ⅰs
Histology IN TA LGD TA LGD IN TA LGD TA LGD
Spigelman 0 Ⅱ° Ⅰ° 0 Ⅲ° Ⅱ°
TA: Tubular adenoma; LGD: Low grade dysplasia.
Table 8  Features of bulbal polyps identified by fujinon intelligent color enhancement
P15 P16-P17 P18 P19 P20-P21
Kudo ⅢS Ⅳ ⅢS ⅢL ⅢS
Size (mm) 5 6-10 6-10 5 5
Paris CL Ⅱa Ⅱb Ⅱa Ⅱb Ⅱb
Histology TA LGD TA LGD TA LGD TA LGD TA LGD
Spigelman Ⅰ° Ⅱ° Ⅱ° Ⅰ° Ⅰ°
TA: Tubular adenoma; LGD: Low grade dysplasia.
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second to advanced and metastatic colorectal cancer. A 
regular and careful program of endoscopic surveillance is 
worthwhile in identifying early pre­malignant lesions.
Gastric polyps, particularly fundic polyps, are con­
sidered always non­neoplastic lesions, also in FAP 
and non­FAP patients; nonetheless high rate of their 
prevalence (20%­88%)[6,9­11] and several cases of 
dysplasia in FGPs in FAP have been recently reported, 
with rate of incidence up to 54%[9­11,18].
Chromoendoscopy, both traditional and virtual, 
has been proven to be a good tool to increase polyps 
identification rate and to predict their histology[29­32]. 
Only one study was published on the use of FICE in 
the evaluation of duodenal lesions[44]. This study was 
conducted using a double balloon enteroscopy on patients 
with duodenal lesions. In this study only two FAP patients 
were included and FICE enhanced mucosal pattern 
of these polyps, and it correlated with the increase of 
detection of more lesions.
However, neither previous studies using traditional 
chromoendoscopy nor FICE, were conducted in evaluation 
of gastric polyps in FAP patients. To the best of our 
knowledge, our study is the first that has assessed the 
role of FICE in FGPs dysplasia identification and in the 
gastroduodenal polyps characterization in FAP subjects.
In agreement with the literature’s data, the pre­
valence of gastric polyps was relatively elevated (90.8%), 
while duodenal polyps were diagnosed in 68.4% of 
patients, slightly lower than the reported literature value.
In the majority of FAP subjects (62/76; 83.3%), 
gastric polyps were so numerous that they carpeted 
the fundic mucosa, making difficult identifying dysplasia 
by random biopsies on the basis of the total number 
of polyps, as indicated in a recent study conducted by 
Bianchi et al[9]. Consequently, having an endoscopic 
technique able to target fundic biopsies is important to 
overcome this issue. Moreover, Bianchi et al[9] reported 
a prevalence of dysplasia in fundic polyps of 42%, while 
we have found only fundic gland polyps without displastic 
or adenomatous areas, although we have followed their 
sampling method. A possible explanation to this marked 
mismatch, could lie in the size of the polyps removed: we 
did found only subcentimetric polyps, while Bianchi et al[9] 
have demonstrated that the risk of dysplasia correlated 
with polyp size. No polyps removed had suspected 
superficial features according to Kudo classification, 
while Bianchi et al[9] did not adopted any classification 
to describe mucosal and vascular pattern; consequently 
we don’t know if their removed polyps had or not a 
suspected pattern.
FICE pointed our attention on 10 fundic polyps, that 
seemed suspected for harboring adenomatous tissue; 
Table 9  Features of duodenal polyps identified by white light endoscopy
Kudo Size (mm) Paris CL Histology Spigelman
P1-P4 Ⅳ 11-20 Ⅱa TA LGD Ⅲ°
P5-P7 V 6-10 Ⅱa TA LGD Ⅱ°
P8-P11 Ⅳ 5 Ⅱb TA LGD Ⅱ°
P12-P16 ⅢS 6-10 Ⅱa TVA LGD Ⅲ°
P17-P27 ⅢS 5 Ⅱa TA LGD Ⅱ°
P28-P34 ⅢS 5 Ⅱa TA LGD Ⅰ°
P35-P40 ⅢS 5 Ⅱb TA LGD Ⅱ°
P41-P43 ⅢS 5 Ⅰs TA LGD Ⅱ°
P44-P47 ⅢS 5 Ⅰs TA LGD Ⅰ°
P48-P50 ⅢS 11-20 Ⅱa TA LGD Ⅱ°
P51-P58 ⅢL 5 Ⅱb TA LGD Ⅱ°
P59-P65 ⅢL 5 Ⅱa TA LGD Ⅱ°
P66-P68 ⅢL 6-10 Ⅱa TA LGD Ⅱ°
P69-P72 ⅢL 6-10 Ⅱa TA LGD Ⅲ°
P73-P79 ⅢL 6-10 Ⅱb TA LGD Ⅱ°
P80-P84 Ⅱ 5 Ⅱa TA LGD Ⅲ°
P85-P91 ⅢL 5 Ⅱb IN Ⅱ°
P92-P94 ⅢS 5 Ⅱa IN Ⅰ°
IN: Inflammatory; TA: Tubular adenoma; LGD: Low grade dysplasia.
Table 10  Features of duodenal polyps identified by fujinon intelligent color enhancement
P95-P97 P98-P100 P101-P102 P103-P105
Kudo Ⅳ Ⅳ V Ⅳ
Size (mm) 5 6-10 6-10 5
Paris CL Ⅱa Ⅱb Ⅱb Ⅱb
Histology TA LGD TA LGD TA LGD TA LGD
Spigelman Ⅰ° Ⅱ° Ⅱ° Ⅱ°
TA: Tubular adenoma; LGD: Low grade dysplasia.
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however histological results did not confirmed this 
suspect and all of polyps resulted fundic gland polyps. In 
this case, FICE has not increased the identification rate of 
dysplasia or adenomatous tissue in fundic polyps.
Prevalence of patients with antral adenomas was 
about 21.1% (16/76), more than reported in the Western 
World data, but consistent with Japanese findings. The use 
of FICE could explain our result, since it has increased the 
identification rate of antral adenomas compared to white 
light, with a difference near to statistical significance (P = 
0.0857). 
The very low specificity of the method (12.0%) could 
be explained by the presence of phlogosis (in fact almost 
all false positive harbored flogistic areas) able to distort 
the mucosal and vascular pattern, specifically enhanced 
by virtual chromoendoscopy.
Therefore, FICE allows to identify a greater number 
of adenomas to the detriment of a greater number 
of biopsies. Anyway this approach didn’t determine a 
different timing in the surveillance program, but changed 
the attention on the antral evaluation during the following 
endoscopies. In duodenal bulb FICE was able to identify 
more adenomas than traditional endoscopy (P = 0.03). 
Furthermore, all patients with FICE-identified adenomas 
had polyps in the duodenum too, thus the identification 
of bulbar adenomas didn’t modify surveillance timing.
Taking into account also bulbar polyps, duodenal 
adenomas prevalence in FAP patients was 68.4%, with 
low Spigelman stages (9.2% stage Ⅲ e 0% stage Ⅳ). 
In duodenum, FICE has allowed to see a greater number 
of adenomas than white light (P < 0.001), without no 
modifications of Spigelman stage neither identification of 
high grade dysplasia.
Among FICE identified polyps, 4 lesions were 
suspected for high grade dysplasia, but three were 
inflammatory polyps at histopathological examination 
and one was a tubular adenoma with low grade of 
dysplasia. Other 7 polyps (Kudo IV) had an increased 
capillary density but they were tubular adenomas with 
low grade of dysplasia.
Finally, in duodenum, FICE increased the polyps 
detection rate but didn’t change any Spigelman stage 
determined with conventional endoscopy. These data 
are in agreement with the little size and the absence of 
high grade dysplasia. Moreover this method wasn’t able 
to modify FAP patients’ prognosis, polyps’ surveillance 
program and their therapeutic management. We did not 
find any relationship between the presence of gastric 
polyps, duodenal polyposis and high Spigelman stage (P 
= 1).
Adenomas were 435 and 81 of them were diagnosed 
only by FICE that was able to identify a significative 
higher number of adenomas (P = 0.0062). Overall, FICE 
has specificity, sensitivity,positive and negative predictive 
values higher than traditional endoscopy referring to 
adenomas (96.0% vs 7.1%; 98.8% vs 80.2%; 90.3% 
vs 44.9%; 98.8% vs 27.6%, respectively; P < 0.0001). 
Conversely, it wasn’t possible to correlate for high grade 
dysplasia due the absence of dysplastic lesions according 
to the histopathological examination.
The FICE identified lesions (106/468; 22.6%) were 
mostly flat (67.9%; P = 0.029) and small (all below 
1 cm). According to already published data, FICE was 
particularly able to identify polyps with these features. It 
isn’t clear if this ability might have clinical and procedural 
consequences.
In summary, in our study, FICE, like traditional 
endoscopy, could not identify any adenoma at risk of 
malignant transformation probably as a consequence of 
patients features (e.g., favorable genotype, recent EGD).
Nonetheless FICE significantly increases adenoma 
detection rate (P = 0.0062) but does not change any 
Spigelman stage and thus does not modify patient’
s prognosis, surveillance program and treatment 
strategies. Probably a careful patient selection, an accurate 
histological examination, a concomitant use of lateral 
viewing endoscope, could make FICE gain that role who 
everybody expects in FAP patient.
COMMENTS
Background
Familial adenomatous polyposis (FAP) is an autosomal dominant inherited 
syndrome characterized by the development of colorectal cancer by the 
age of 40 years in nearly 100% of individuals. The use of colon endoscopic 
surveillance and prophylactic colectomy have strongly reduced mortality in FAP 
patients leading to the introduction of surveillance strategies for the prevention 
of other extracolonic malignancies (e.g., in the duodenum and in the stomach). 
Duodenal adenomatous polyps are common manifestations of FAP found in 
30% to 90% of patients. Duodenal cancer is the second most common cause 
of disease-related mortality in patients with FAP, only the second to advanced 
and metastatic colorectal cancer. Gastric polyps, particularly fundic polyps, are 
considered always non-neoplastic lesions, also in FAP and non-FAP patients; 
nonetheless high rate of their prevalence (20%-88%) and several cases of 
dysplasia in FGPs in FAP have been recently reported, with rate of incidence 
up to 54%.
Research frontiers
The observation of the pit and capillary patterns of the mucosal glands and 
the mucosa, respectively, by chromoendoscopy might predict the histology of 
mucosal lesions. 
Innovations and breakthroughs
Chromoendoscopy is a staining method that uses biocompatible dye agents 
which accumulate within crypt orifices during endoscopy. Chromoendoscopy 
has difficulty in achieving complete and even coating of the mucosal surface 
with the dye, requires the extra cost for the of the dye spraying equipments and 
extra time to perform the procedure. Fujinon Intelligent Color Enhancement 
(FICE™, Fujinon Corp, Saitama, Japan) is a spectral estimation technique 
based on arithmetically processing of a white-light image captured by a video 
endoscope and sent to the spectral-estimation matrix-processing circuit. 
Preliminary studies suggested that FICE successfully achieves enhancements 
of real-time observations of mucosal and microvascular patterns and may 
discriminate between adenomatous and non-adenomatous polyps and it may 
identify the presence of dysplasia. In the study, FICE, like traditional endoscopy, 
could not identify any adenoma at risk of malignant transformation probably 
as a consequence of patients features. However FICE significantly increases 
adenoma detection without changing patient’s prognosis, surveillance program 
and treatment strategies. Probably a careful patient selection, an accurate 
histological examination, a concomitant use of lateral viewing endoscope, could 
make FICE gain that role who everybody expects in FAP patient.
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Applications
The timing of endoscopic and histology surveillance is currently a great 
challenge. Spectral estimation by fujinon intelligent color enhancement (FICE) 
may identify dysplasia and discriminate between adenomatous and non-
adenomatous polyps. 
Terminology
FAP is an autosomal dominant inherited syndrome who invariably develops to 
colorectal cancer by the age of 40 years in nearly 100% of individuals. Several 
endoscopic imaging techniques have been proposed to enhance the detail of 
these patterns. Among these, chromoendoscopy is a staining method applied 
in endoscopy that uses biocompatible dye agents which accumulate within 
crypt orifices. FICE is a modern endoscopic spectral estimation technique that 
successfully enhances the observation of mucosal and micro-vascular patterns.
Peer-review
The presented results, obtained with 76 FAP patients, indicate that FICE assay 
offers considerable advantage over traditional chromoendoscopy to discriminate 
between adenomatous and non-adenomatous polyps. The authors, however, 
caution that the application of FICE to FAP patients while helpful in prediction 
the histology of the mucosal lesion and significantly increases the detection of 
adenomas, do not change the prognosis and treatment. 
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